| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,830 | 0,860 | 13:01 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders | 380 | GlobeNewswire (Europe) | TORONTO, June 09, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. "Spectral" or the "Company" (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock... ► Artikel lesen | |
| 04.06. | Spectral Medical Inc: Spectral Medical talks Tigris top-line mortality data | 1 | Stockwatch | ||
| 04.06. | Stocks in Play: Spectral Medical Inc. | - | Baystreet.ca | ||
| SPECTRAL MEDICAL Aktie jetzt für 0€ handeln | |||||
| 29.05. | Spectral Medical Inc: Spectral submits FDA PMA for PMX sepsis therapy.255 | 2 | Stockwatch | ||
| 29.05. | Spectral Medical Inc.: Spectral Medical Announces PMA Submission to U.S. FDA for PMX | 140 | GlobeNewswire (Europe) | TORONTO, May 29, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock... ► Artikel lesen | |
| 08.05. | Spectral Medical GAAP EPS of -$0.01, revenue of $891M | 2 | Seeking Alpha | ||
| 08.05. | Spectral Medical Inc.: Spectral Medical Announces First Quarter 2026 Financial Results and Provides Corporate Update | 384 | GlobeNewswire (Europe) | PMA submission targeted for May 29, 2026 in alignment with FDAVantive commits to additional funding support ahead of PMA acceptance milestone TORONTO, May 08, 2026 (GLOBE NEWSWIRE) -- Spectral Medical... ► Artikel lesen | |
| 01.04. | Bloom Burton & Co. Inc.: Spectral Medical Inc. Announces Participation in the 2026 Bloom Burton & Co. Healthcare Investor Conference | 510 | Newsfile | Toronto, Ontario--(Newsfile Corp. - April 1, 2026) - Spectral Medical Inc. (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, will be participating... ► Artikel lesen | |
| 26.03. | Spectral Medical reports Q4 results | 1 | Seeking Alpha | ||
| 26.03. | Spectral Medical Inc.: Spectral Medical Announces Fourth Quarter and Fiscal 2025 Results and Provides Corporate Update | 210 | GlobeNewswire (Europe) | TORONTO, March 26, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock... ► Artikel lesen | |
| 24.03. | Spectral Medical Inc: Spectral, Vantive release Tigris results in Lancet | 1 | Stockwatch | ||
| 24.03. | Spectral Medical Inc.: Spectral Medical and Vantive Announce Publication of Complete Results from Spectral's Tigris Trial in the Lancet Respiratory Medicine | 362 | GlobeNewswire (Europe) | Tigris publication confirms positive results for primary and key secondary endpoints with 95.3% and 99.4% probability of benefit for PMX at 28-day and 90-day mortality After adjusting for baseline... ► Artikel lesen | |
| 26.02. | Spectral Medical Inc: Spectral delays seeking premarket OK for PMX to mid-May | 3 | Stockwatch | ||
| 26.02. | Stocks in Play: Spectral Medical Inc | - | Baystreet.ca | ||
| 26.02. | Spectral Medical Inc.: Spectral Medical Provides Update on PMA Submission Timing for PMX-20R | 171 | GlobeNewswire (Europe) | TORONTO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock... ► Artikel lesen | |
| 07.11.25 | Spectral Medical Inc.: Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update | 272 | GlobeNewswire (Europe) | PMA submission targeted for Q1 2026 following positive Tigris results and ongoing FDA interactionsCompany to host Corporate Update call on Wednesday, December 10, 2025 TORONTO, Nov. 07, 2025 (GLOBE... ► Artikel lesen | |
| 25.08.25 | Spectral Medical Inc.: Spectral Medical Receives US$3 Million From Vantive | 430 | GlobeNewswire (Europe) | TORONTO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock... ► Artikel lesen | |
| 13.08.25 | XFRA SD4: WIEDERAUFNAHME/RESUMPTION | 437 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| 13.08.25 | XFRA SD4: AUSSETZUNG/SUSPENSION | 287 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILSPECTRAL MEDICAL... ► Artikel lesen | |
| 12.08.25 | Spectral Medical Inc.: Spectral Medical and Vantive Announce Topline Results from Spectral's Tigris Trial Evaluating PMX Hemoadsorption Therapy for Endotoxic Septic Shock | 306 | GlobeNewswire (Europe) | Results exceed prespecified primary endpoint of 95% posterior probability of benefit for PMX on 28-day mortality Pooled absolute risk reduction of 8.3%; Relative risk reduction of 18% Key secondary... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 39,470 | +1,99 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| RHOEN-KLINIKUM | 12,600 | 0,00 % | Tag des Cholesterins am 12. Juni 2026 / Experten am RHÖN-KLINIKUM Campus Bad Neustadt appellieren: "Jeder sollte seinen LDL-Wert kennen" | Bad Neustadt a.d. Saale (ots) - Hohe Blutfette erhöhen das Risiko für Herzinfarkt, Schlaganfall und Durchblutungsstörungen der GefäßeHerz-Kreislauf-Erkrankungen sind nach wie vor die häufigste Todesursache... ► Artikel lesen | |
| ROKU | 104,78 | +1,35 % | Netflix Is Down 12% in 2026, While Roku Is Up 11%. Which Streaming Stock Is the Better Buy in June? | ||
| SERNOVA BIOTHERAPEUTICS | 0,097 | -0,20 % | Sernova Biotherapeutics: Sernova Biotherapeutics Announces Closing of Recently Approved Financings | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - April 23, 2026) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSHO) (XETRA: PSHO) ("Sernova" or the "Company"), a leading... ► Artikel lesen | |
| FAMICORD | 3,820 | 0,00 % | EQS-News: FamiCord AG verzeichnet erwartungsgemäß schwächeren Start in das Geschäftsjahr 2026 bei anhaltendem Gegenwind aus dem Markt und robuster Abonnementbasis | EQS-News: FamiCord AG
/ Schlagwort(e): Quartalsergebnis
FamiCord AG verzeichnet erwartungsgemäß schwächeren Start in das Geschäftsjahr 2026 bei anhaltendem Gegenwind aus dem Markt... ► Artikel lesen | |
| M1 KLINIKEN | 17,340 | -2,47 % | M1 Kliniken verdient im Beauty-Geschäft deutlich mehr | Nach dem Verkauf ihrer Pharmahandels-Tochter konzentriert sich die M1 Kliniken AG nun auf das Geschäft mit Schönheitsbehandlungen: Im ersten Quartal 2026 kletterte das EBIT des Beauty-Segments um 37... ► Artikel lesen | |
| GERATHERM MEDICAL | 2,670 | -2,91 % | EQS-AFR: Geratherm Medical AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Geratherm Medical AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Geratherm Medical AG: Vorabbekanntmachung... ► Artikel lesen | |
| PLUS THERAPEUTICS | 4,585 | +0,22 % | PLUS THERAPEUTICS, INC. - 8-K, Current Report | ||
| BAXTER | 17,825 | +0,71 % | Dividendenbekanntmachungen (29.05.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AGNC INVESTMENT CORP US00123Q1040 0,12 USD 0,1029 EUR AGREE REALTY CORPORATION US0084921008 0,267 USD 0,2291 EUR ALLIED PROPERTIES... ► Artikel lesen | |
| BILLIONTOONE | 99,65 | 0,00 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 27,690 | 0,00 % | PROCEPT BioRobotics shares slide after Leerink downgrade cites rising competitive risks | ||
| ALIGNMENT HEALTHCARE | 20,225 | -0,07 % | Alignment Healthcare (ALHC) Soars 25.1%: Is Further Upside Left in the Stock? | ||
| BRIGHTSPRING HEALTH SERVICES | 63,08 | 0,00 % | Goldman Sachs initiates BrightSpring Health stock at Buy with $71 target | ||
| GENEDX | 60,99 | 0,00 % | Sema4.ai's autonomous agent building platform gets simpler to use, adds deeper business context and more | ||
| PRIVIA HEALTH GROUP | 23,360 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2026 Financial Results | Strong First Quarter Performance and Operating ExecutionReiterated Full-Year 2026 Guidance Reflects Continued Momentum ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq:... ► Artikel lesen |